首页> 外文期刊>American Journal of Physiology >Increased secretion of urokinase-type plasminogen activator by human lung microvascular endothelial cells.
【24h】

Increased secretion of urokinase-type plasminogen activator by human lung microvascular endothelial cells.

机译:人肺微血管内皮细胞分泌的尿激酶型纤溶酶原激活物增加。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Human lung microvascular endothelial cells (HLMECs) secreted 1.5-15 times more urokinase-type plasminogen activator (uPA) antigen than human hepatic microvascular endothelial cells, human umbilical vein endothelial cells (HUVECs), angioma endothelial cells, and lung fibroblasts. All of these cells also secreted a 100-fold greater amount of plasminogen activator inhibitor-1 than of uPA antigen, and uPA activities were not detected in the culture medium. The expression of uPA mRNA in HLMECs was higher (100-fold) compared with HUVECs, angioma endothelial cells, and lung fibroblasts. HLMECs secreted uPA antigen on both the luminal and basal sides of the cells. On the other hand, HLMECs secreted a 10- to 15-fold lower amount of tissue-type plasminogen activator than HUVECs, mostly on the luminal side. After stimulation with interleukin (IL)-1beta, HLMECs secreted a six- to ninefold amount of uPA antigen. In contrast, no stimulatory effect was observed in HUVECs even under high IL-1beta concentrations. The secretion of uPA and plasminogen activator inhibitor-1 from HLMECs was also enhanced by tumor necrosis factor-alpha and IL-2. These results suggest that HLMECs may contribute not only to the patency of lung vessels but also to the maintenance of alveolar functions through the production and secretion of uPA, especially in the presence of inflammatory cytokines.
机译:人肺微血管内皮细胞(HLMEC)分泌的尿激酶型纤溶酶原激活剂(uPA)抗原的量是人肝微血管内皮细胞,人脐静脉内皮细胞(HUVEC),血管瘤内皮细胞和肺成纤维细胞的1.5-15倍。所有这些细胞还分泌了比uPA抗原高100倍的纤溶酶原激活物抑制剂1,并且在培养基中未检测到uPA活性。与HUVEC,血管瘤内皮细胞和肺成纤维细胞相比,HLMEC中uPA mRNA的表达更高(100倍)。 HLMEC在细胞的管腔和基底侧均分泌uPA抗原。另一方面,HLEMCs分泌的组织型纤溶酶原激活剂的量比HUVEC少10到15倍,主要是在腔侧。用白介素(IL)-1β刺激后,HLMEC分泌了6至9倍的uPA抗原。相反,即使在高IL-1β浓度下,在HUVEC中也未观察到刺激作用。肿瘤坏死因子-α和IL-2也增强了HLMECs中uPA和纤溶酶原激活物抑制剂-1的分泌。这些结果表明,HLMEC不仅可以通过产生和分泌uPA来促进肺血管通畅,而且可以维持肺泡功能,特别是在存在炎性细胞因子的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号